Literature DB >> 11714835

IFN-gamma affects homing of diabetogenic T cells.

A Y Savinov1, F S Wong, A V Chervonsky.   

Abstract

IFN-gamma is a cytokine with pleiotropic functions that participates in immune and autoimmune responses. The lack of IFN-gamma is known to delay the development of autoimmune diabetes in nonobese diabetic (NOD) mice. Splenocytes from diabetic NOD and IFN-gamma knockout (KO) NOD mice transfer diabetes into NOD recipients equally well. However, adoptive transfer of diabetogenic T cells from NOD mice into NOD.IFN-gamma-KO or NOD mice lacking beta-chain of IFN-gamma receptor (NOD.IFN-gammaRbeta-KO) appeared to be much less efficient. We found that IFN-gamma influences the ability of diabetogenic cells to penetrate pancreatic islets. Tracing in vivo of insulin-specific CD8+ T cells has shown that homing of these cells to the islets of Langerhans was affected by the lack of IFN-gamma. While adhesion of insulin-specific CD8+ cells to microvasculature was normal, the diapedesis was significantly impaired. This effect was reversible by treatment of the animals with rIFN-gamma. Thus, IFN-gamma may, among other effects, influence immune and autoimmune responses by supporting the homing of activated T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714835     DOI: 10.4049/jimmunol.167.11.6637

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Memory T-cell trafficking: new directions for busy commuters.

Authors:  Federica M Marelli-Berg; Hongmei Fu; Fabrizio Vianello; Koji Tokoyoda; Alf Hamann
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

2.  Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice.

Authors:  A G S van Halteren; M J Kardol; A Mulder; B O Roep
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

3.  Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet β-cells in recent-onset type 1 diabetes in NOD mice.

Authors:  Cheng Li; Lijuan Zhang; Yanyan Chen; Xiaojie Lin; Tang Li
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

4.  IL-18 is required for self-reactive T cell expansion in NOD mice.

Authors:  Annette M Marleau; Nora E Sarvetnick
Journal:  J Autoimmun       Date:  2011-03-16       Impact factor: 7.094

5.  IκBζ augments IL-12- and IL-18-mediated IFN-γ production in human NK cells.

Authors:  Yashaswini Kannan; Jianhua Yu; Raquel M Raices; Sudarshan Seshadri; Min Wei; Michael A Caligiuri; Mark D Wewers
Journal:  Blood       Date:  2011-01-11       Impact factor: 22.113

6.  Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues.

Authors:  Aaron J Martin; Matthew Clark; Gregory Gojanovich; Fatima Manzoor; Keith Miller; Douglas E Kline; Y Maurice Morillon; Bo Wang; Roland Tisch
Journal:  JCI Insight       Date:  2016-10-20

7.  Interferon-γ Limits Diabetogenic CD8+ T-Cell Effector Responses in Type 1 Diabetes.

Authors:  John P Driver; Jeremy J Racine; Cheng Ye; Deanna J Lamont; Brittney N Newby; Caroline M Leeth; Harold D Chapman; Todd M Brusko; Yi-Guang Chen; Clayton E Mathews; David V Serreze
Journal:  Diabetes       Date:  2016-12-05       Impact factor: 9.461

8.  An evolving autoimmune microenvironment regulates the quality of effector T cell restimulation and function.

Authors:  Rachel S Friedman; Robin S Lindsay; Jason K Lilly; Vinh Nguyen; Caitlin M Sorensen; Jordan Jacobelli; Matthew F Krummel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-10       Impact factor: 11.205

9.  Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes.

Authors:  Subha Karumuthil-Melethil; Nicolas Perez; Ruobing Li; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

10.  T cell extravasation: demonstration of synergy between activation of CXCR3 and the T cell receptor.

Authors:  Peter Newton; Graeme O'Boyle; Yvonne Jenkins; Simi Ali; John A Kirby
Journal:  Mol Immunol       Date:  2009-09-20       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.